Pharmaceuticals, Biotechnology and Life Sciences
Data show for the first time a new ultra long-acting cabotegravir formulation (CAB-ULA) that doubles the current dosing interval Pharmacokinetic,…
Proprietary methods to standardize expected values of brain activity pave the way for the development of biomarkers in CNS disorders.…
Event sponsored by Glaxo Smith Kline will feature speakers from across life sciences WATERTOWN, Mass.–(BUSINESS WIRE)–EnPlusOne Biosciences, Inc., a biotechnology…
DALLAS & SAN FRANCISCO–(BUSINESS WIRE)–SmithRx, a transparent and 100% pass-through PBM, and Mark Cuban Cost Plus Drug Company, PBC (Cost…
With this agreement, Biomunex, already co-inventor and 50% co-owner of this innovative approach, has licensed complementary exclusive rights from Institut…
NASHVILLE, Tenn.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC) (“Revance” or the “Company”) today announced the pricing of an underwritten public offering…
Ten emerging companies developing innovative mental health solutions will receive $1 million total in investment along with mentoring, coaching, and…
Initial data from adult patients with PMM2-CDG showed promising evidence of clinical benefit with GLM101 Notable improvements were seen in…
-Top-line data including safety, tolerability, and biomarker activity anticipated this summer- -This Phase 1 clinical study data will support further…
BERWYN, Pa.–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the…